Mirae Asset Global Investments Co., Ltd. 89bio, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in 89bio, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,937 shares of ETNB stock, worth $24,553. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,937
Previous 16,724
82.44%
Holding current value
$24,553
Previous $194,000
88.14%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ETNB
# of Institutions
157Shares Held
107MCall Options Held
65KPut Options Held
1.2M-
Ra Capital Management, L.P. Boston, MA14.2MShares$119 Million1.71% of portfolio
-
Janus Henderson Group PLC London, X013.3MShares$111 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.03MShares$67.1 Million2.69% of portfolio
-
Bvf Inc San Francisco, CA7.57MShares$63.3 Million1.85% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$61.7 Million0.99% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $389M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...